Research and experimental development on natural sciences and engineering
SCLEROMAX AS
Operating profit
NOK −29,000
Equity
NOK −92,000
Incorporated
2021
Share capital
NOK 30,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2025 | Trend |
|---|---|---|
| Total operating costs | 29k | |
| Operating profit (EBIT) | −29k | |
| Net financial items | 1 | |
| Profit for the year | −29k |
Balance sheet
| Post | 2025 | Trend |
|---|---|---|
| Total assets | 2k | |
| of which current assets | 2k | |
| Equity | −92k | |
| Total liabilities | 94k |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.